The wife of Senator Olusola Adeyeye representing Osun Central constituency at the National Assembly, Prof. Moji Christianah Adeyeye has been appointed as the Director-General of the National Agency for Food and Drug Administration and Control, NAFDAC by President Buhari.

Below is the biography of the newly appointed Director-General..

Prof. Moji is a Professor of Pharmaceutics, Manufacturing Science and Drug Product Evaluation and she is the President of Elim Pediatric Pharmaceuticals, located at 1600 Golf Rd., Suite 1200, Rolling Meadows, IL 60008.

PROFESSIONAL PROFILE
______________________________________________________________________________

1. Fellow, Nigerian Academy of Science
2. Academic Research Fellow, American Association of Colleges of Pharmacy (AACP)
3. J. William Fulbright Senior Specialist, Obafemi Awolowo, University, Ile-Ife, Nigeria
4. First African Woman Fellow, American Association of Pharmaceutical Scientists (AAPS) - Only 3% of academia receives such recognition internationally
5. J. William Fulbright Scholar Award for African Regional Research Program on AIDS and AIDS-Related Research, University of Lagos, Idi-Araba, Lagos and National Institute for Pharmaceutical Research and Development (NIPRD), Idu, FCT, Nigeria
6. Expert in drug development, translational research and regulatory science
7. Expert in pediatric HIV/AIDS pharmaceutical products and clinical trials
8. Organizer and presenter at meetings; and delivered seminars on drug shortage and role of non-active ingredients in pharmaceutical products to international audience (including FDA and pharmaceutical companies) at AAPS conferences
9. Author of 60 peer-reviewed research articles, 8 book/book chapters, and books
10. Inventor and author of 6 patents
11. Presenter of over 150 research and scholarly work at national and international meetings
12. Supervisor of 12 MS and 7 PhD students
13. Co-advisor of 18 graduate students as research committee member
14. Innovator in new program development – built Biopharmaceutical Sciences department at Roosevelt University College of Pharmacy (RUCOP), hired faculty, built research laboratories, procured equipment to enhance the capacity of the faculty members and engage community stakeholders (pharmaceutical and biotechnology companies) as advisory board, collaborators and student mentors
15. Successfully directed FDA, Nigeria’s NAFDAC and NHREC-approved Phase I clinical trial (Bioequivalence) of pediatric ARV drugs at Baptist Medical Center, Ogbomoso (now Bowen University Teaching Hospital)
16. Created Research Advisory Council at RUCOP to facilitate collaboration with the pharmaceutical industry in teaching, research and student mentoring

EDUCATION, POSITIONS, CONSULTANCY AND AWARDS

EDUCATION

University of Nigeria, Nsukka, Nigeria B. Pharm 1976, Pharmaceutics, University of Georgia, Athens, GA, USA M.S 1985, Pharmaceutics, University of Georgia, Athens, GA, USA PhD 1988

ACADEMIC AND ADMINISTRATIVE POSITIONS

2014 - 2017 Faculty Trustee, Roosevelt University Board
2010 - 2018 Professor of Pharmaceutics, Manufacturing Science and Drug Product Evaluation, College of Pharmacy, Roosevelt University, Schaumburg, IL
2010 - 2017 Chair, Department of Biopharmaceutical Sciences, College of Pharmacy, Roosevelt University, Schaumburg, IL
2003–2010 Professor of Pharmaceutics and Pharmaceutical Technology, Division of Pharmaceutical Sciences, School of Pharmacy, Duquesne University, Pittsburgh, PA, USA
2009 - Visiting Professor, Nnamdi Azikwe University, Awka, Anambra State, Nigeria

• Delivered lectures to professional pharmacy students in Formulation and Development
• Assessed students’ learning through formative and summative mechanisms and grading
• Presented seminars in Drug Development and Careers in Pharmacy

2009 - 2010 Chair, American Association of Pharmaceutical Scientists (AAPS) Membership Strategic Oversight Committee (MSOC)
2009 - Fulbright Specialist Visiting Scholar (Global/Public Health) Obafemi Awolowo University, Nigeria,

• Taught Formulation and Development and Pharmaceutical Manufacturing to professional pharmacy students
• Presented seminars in Drug Development and Careers in Pharmacy)

2006- Adjunct Professor, Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, University of Lagos, Lagos, Nigeria
2004-2005 Senior Fulbright Scholar, Faculty of Pharmacy, University of Lagos, Idi-Araba, Lagos and National Institute for Pharmaceutical Research and Development, Abuja, FCT

• Conducted research on Quality Assurance and Bioequivalence of Anti-retroviral Drugs for Treatment of HIV/AIDS
• Taught Formulation and Development and Pharmaceutical Manufacturing; Assessment of learning through exams and grading; Presentation of seminars in Drug Development)

2004- President, Drugs for AIDS and HIV Patients (DAHP) – a faith based tax-exempt organization. USA) Project: Prevention of HIV/AIDS Among Nigerian Youths Prevention of Mother-to-child Transmission and Care for Orphans and Vulnerable Children in Lagos, Osun and Oyo States
1999-2004 President, Nigerian Association of American Pharmaceutical Scientists
1994 -2003 Associate Professor of Pharmaceutics, Duquesne Pittsburgh, PA, USA

1989 – 1994 Assistant Professor, Duquesne University, Pittsburgh, PA
1988 – 1989 Assistant Professor, School of Pharmacy, University of Puerto Rico, San Juan, Puerto Rico
1979 - 1980 Head of Pharmacy, Baptist Hospital, Ogbomoso, Oyo State, Nigeria
1976 - 1979 Pharmacist, University College Hospital, Ibadan, Oyo State, Nigeria

CONSULTANCY

Expert Witness in Pharmaceutical Products litigations
• Opinions on the Pharmaceutical Science of Products under Litigation
• Investigative Pharmaceutical Development and Analysis
• Pre-Court Trial Deposition

AWARDS and HONORS

2016 Fellow, Nigerian Academy of Science
2015 Academic Research Fellow, American Association of Colleges of Pharmacy (AACP)
2013 Recognition Award in Community Partnership, Northwest Illinois Educational
Council for Student Success (NECSS)
• For significant contribution in the field career exploration and technology education of high school students
2011 Recognition Service Award, AAPS Manufacturing Science Engineering Section
2009 J. William Fulbright Senior Specialist Candidate, Obafemi Awolowo University, Ile-Ife, Nigeria
2008 Fellow, American Association of Pharmaceutical Scientists (AAPS)
2008 Duquesne University Presidential Award for Excellence in Service to the Mission
2008 Award for Excellence in Service, School of Pharmacy, Duquesne University
2006- J. William Fulbright Senior Specialist Candidate
2004-2005 J. William Fulbright Scholar Award for African Regional Research Program on AIDS and AIDS-Related Research
2003 Duquesne University Presidential Award for Excellence in Scholarship
2001, 2003 Award for Excellence in Scholarship, School of Pharmacy, Duquesne University
2003 Award for Excellence in Scholarship, Division of Pharmaceutical Sciences, Duquesne University
1998 Recognition: Focus Group Member: Capsugel Expert System for Development of Hard Gelatin Capsule Dosage Form
1991/1992 Marquis Who is Who of American Women
1985/1986 Award for Excellence in Research Program by a Graduate student, School of Pharmacy, University of Georgia
1983 Graduate Fellowship, American Association of University Women (AAUW)


INSTRUCTION, SEMINARS AND RESEARCH IN DRUG PRODUCT QUALITY CONTROL, REGULATORY GOOD CLINICAL PRACTICE AND APPROVAL

COURSES/TOPICS TAUGHT TO GRADUATE AND PROFESSIONAL STUDENT
(1988 – PRESENT)
• Drug Delivery and Industrial Pharmacy
• Dosage Formulation and Development (including solid state characterization of excipients, drug-excipient interaction), Modified Release Technology, Excipients, etc.
• Pharmaceutical Manufacturing
• FDA Current Good Manufacturing Practices,
• Solid Dosage Forms (Tablets and Capsules) Development
• Manufacturing and Role of Excipients
• Safety of Excipients
• Manufacturing Equipment Cleaning Validation
• Pharmaceutical Site Inspection and Violation
• Pharmaceutical Unit Processes – Processes used in Solids Development and Influence of Excipients on Manufacturability
• Pharmaceutical Unit Processes - Processes used in Liquids (suspensions, emulsions and solutions)

SEMINARS (ORGANIZED and TAUGHT)

• 1994: Technomic Seminar Series: Pharmaceutical Excipients: Towards the Twenty-
First Century, Meadowlands, New Jersey.
1995: Technomic Seminar Series: Pharmaceutical Excipients: Towards the Twenty
First Century, Basel, Switzerland.
• 1997 – 2000: Duquesne University Pharmaceutical Seminar Series: Pharmaceutical
Unit Processes and Solid Dosage Form Development: Industry and Regulatory
Perspectives. Pittsburgh
• 1998 – 2000: Duquesne University Pharmaceutical Seminar Series: Pharmaceutical
Unit Processes and Liquids/Semisolids Solid Dosage Form Development: Industry
and Regulatory Perspectives. Pittsburgh
• 2005: AAPS 19th Annual Meeting, Nashville, Tennessee, Preformulation and
Pharmaceutical Product Development. Symposium Program Planning Committee
and Chair.
• 2007: AAPS 21st Annual Meeting, San Diego, November. Drug-Excipient Interaction
and Characterization, Roundtable
• 2012: AAPS 26th Annual Meeting, Chicago, Illinois, Overcoming Drug Shortages in
the USA. Roundtable/Hot Topic.
Prof Moji Adeyeye CV April 2017 5
2010: ORGANIZED AND CO-TAUGHT GOOD CLINICAL PRACTICE
o Presented part of the following 12 Modules by Clintriad Pharma Services, July 30 & 31
2010, Bowen University teaching Hospital (BUTH), Ogbomoso, Oyo State, Nigeria
o Audience: medical doctors, nurses, social workers of BUTH
o Ethical Issues in Clinical Research: Development of ICH GCPs
o The Drug Development Process
o Roles and Interactions of Key Players in Clinical Research
o Trial Start-Up Process
o Essential Documents and Subject records; Subject Recruitment and retention
o Informed Consent Process; Site Visits
o Study Coordinator’s Responsibilities; Adverse Events and Safety Reporting
o Institutional review Board
o Readiness for Sponsor’s Audit and regulatory Inspections
DRUG PRODUCT APPROVAL
Investigational New Drug (IND) Application Submission To The FDA
• Zidovudine, Lamivudine, Nevirapine Fixed dose and fast disintegrating tablets for
suspension and granules for reconstitution. IND No. - 108,518. 2010
• The IND was submitted in partnership with Elim Pediatric Pharmaceuticals Inc. The
emphasis was on optimization of performance (disintegration and taste) of pediatric antiretrovirals
drugs (using various excipients) for the treatment of HIV/AIDS
• Phase I (Bioequivalence) Clinical Trial - ClinicalTrials.gov Identifier: NCT01469520
• Submission of NDA (505.b.2) for product registration - In preparation
Investigational New Drug (IND) Application Submission to the National Agency For Food
and Drug Administration (NAFDAC), Nigeria
• Zidovudine, Lamivudine, Nevirapine Fixed dose and Fast Disintegrating Tablets for
Suspension and Granules for Reconstitution
o Submitted in partnership with Elim Pediatric Pharmaceuticals Inc. July 2010
• Phase I (Bioequivalence) Clinical Trial
• Approval of Clinical Protocol - January 2014
• Request to submit application for registration of imported drugs – May 2014

- Read full bio and more @ http://www.exlinklodge.com/2017/11/biography-of-newly-appointed-dg-of.html

cc lalasticlala